Low dose cyclosporine A in the treatment of resistant proliferative lupus nephritis

Abstract

Low-dose CsA could induce renal remission and ameliorate the SLE disease activity in patients with resistant proliferative lupus nephritis and it would be a safe drug for treatment of these patients.